CIK 0000920148 · Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 992588107
- Phone
- 3362291127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,195,768
- in 4 filings, $1.1M under 10b5-1 plans
Net −$2,195,768. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-11 | Davis Jeffrey A. Director | Option exercise | +897 | 5,460 | ||
| 2026-02-11 | Davis Jeffrey A. Director | Option exercise · Restricted Stock Unit | −897 | 773 | ||
| 2026-02-11 | ANDERSON KERRII B Director | Option exercise | +897 | 9,563 | ||
| 2026-02-11 | ANDERSON KERRII B Director | Option exercise · Restricted Stock Unit | −897 | 773 | ||
| 2026-02-10 | Schechter Adam H President & CEO | Grant or award · Non-qualified Stock Options | +31,700 | 31,700 | ||
| 2026-02-10 | Schechter Adam H President & CEO | Grant or award · Restricted Stock Unit | +10,440 | 25,870 | ||
| 2026-02-10 | Meltzer Jonathan C EVP, Operations | Sale 10b5-1 | −91 | $276.79 | $25K | 2,696.33 |
| 2026-02-10 | Meltzer Jonathan C EVP, Operations | Grant or award · Non-qualified Stock Options 10b5-1 | +1,900 | 1,900 | ||
| 2026-02-10 | Meltzer Jonathan C EVP, Operations | Grant or award · Restricted Stock Unit 10b5-1 | +620 | 2,937 | ||
| 2026-02-10 | Kyle Kathryn W EVP, Chief Legal Officer | Grant or award · Non-qualified Stock Options | +2,700 | 2,700 | ||
| 2026-02-10 | Kyle Kathryn W EVP, Chief Legal Officer | Grant or award · Restricted Stock Unit | +880 | 2,480 | ||
| 2026-02-10 | Vaughn Bryan T EVP, Diagnostics | Grant or award · Non-qualified Stock Options | +2,200 | 2,200 | ||
| 2026-02-10 | Vaughn Bryan T EVP, Diagnostics | Grant or award · Restricted Stock Unit | +730 | 4,354 | ||
| 2026-02-10 | Wang Julia Aijun Chief Financial Officer, EVP | Grant or award · Non-qualified Stock Options | +7,100 | 7,100 | ||
| 2026-02-10 | Wang Julia Aijun Chief Financial Officer, EVP | Grant or award · Restricted Stock Unit | +2,350 | 5,824 | ||
| 2026-02-10 | Wilkinson Peter J SVP, Chief Accounting Officer | Grant or award · Non-qualified Stock Options | +1,300 | 1,300 | ||
| 2026-02-10 | Wilkinson Peter J SVP, Chief Accounting Officer | Grant or award · Restricted Stock Unit | +440 | 2,664 | ||
| 2026-02-10 | Oyegunwa Akinbolade EVP, CIO & CTO | Grant or award · Non-qualified Stock Options | +2,400 | 2,400 | ||
| 2026-02-10 | Oyegunwa Akinbolade EVP, CIO & CTO | Grant or award · Restricted Stock Unit | +810 | 2,420 | ||
| 2026-02-10 | Summy Amy B. EVP, Chief Marketing Officer | Grant or award · Non-qualified Stock Options | +1,900 | 1,900 |
Page 7 of 14 · 262 trades